Murtaza Khorakiwala – Managing Director, Wockhardt

Murtaza Khorakiwala, managing director of Wockhardt, discusses the company’s vast international expertise in the manufacturing of pharmaceuticals and biopharmaceutical formulations in their 12 US FDA, UK MHRA and EMA compliant manufacturing facilities in India, as well as the out-licensing of its products into other regions to capture and penetrate new markets.  
The Indian market still accounts for about 30-35 percent of the global business, the European market is another 35 percent, US is approximately 20 percent and emerging markets is about 10 percent
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report